Clinical trials
Myocardial Infarct clinical trials
Below are recruiting myocardial infarct clinical trials, each written for real people, not researchers. We’re tracking 318 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06282042Recruiting
Early Fix of Leaky Mitral Valve After Heart Attack
This trial tests an early, minimally invasive procedure to fix a leaky mitral valve using a catheter (a thin tube) after a heart attack. The goal is to see if fixing the valve early can help patients recover better and avoid more serious heart problems.
Afula, AfulaAges 18–99 - NCT07042321Recruiting
Risk factors for blocked heart vessels after emergency angioplasty
This study looks at why some people develop micro-blockages in the heart's small blood vessels after emergency angioplasty (PCI) for a heart attack. If you join, you'll help doctors understand these risks and maybe prevent future problems.
Changsha, Hunan Province,ChinaAges 18 years+ - NCT07382700Enrolling by invitation
Blood markers in heart attack patients treated with stents
This study looks at certain fats in the blood of people having a severe heart attack called STEMI. Researchers want to see if these fats can help understand what happens in the body during a heart attack.
Ningbo, ZhejiangAges 50–70 - NCT06995495Recruiting
Wearable devices to help manage heart attack recovery
This trial tests whether a wearable device can help manage recovery after a heart attack. It might help you track your health and alert your care team if there is a problem.
ShanghaiAges 18–75 - NCT06118281RecruitingPhase 3
Testing ziltivekimab after a heart attack
This study tests a new drug called ziltivekimab to see if it helps people who have recently had a heart attack. The drug is given as an injection and compared to a placebo (a shot with no active medicine).
Alexander City, AlabamaAges 18 years+ - NCT06521047Recruiting
Long-term follow-up for EXCELLENT trial participants
This study looks at the long-term health of people who took part in the EXCELLENT trial. If you finished that trial within the last 10 years, you may be able to join this study to help researchers understand how participants are doing over time.
Mulhouse, FranceAges 18 years+ - NCT07400458Recruiting
Long-term study after Hearticellgram-AMI for heart attack patients
This study checks on people who have already received a treatment called Hearticellgram-AMI for heart attack. It wants to see how they are doing over the long term.
Seoul, GangnamAges Any age - NCT07714746RecruitingPhase 3
Ivabradine for treating cardiogenic shock after heart attack
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
KarachiAges 18–75 - NCT07293923Recruiting
Magenta Elevate™ study for cardiogenic shock
This trial tests a new heart pump called the Magenta Elevate™ to help people whose heart suddenly stops pumping enough blood (cardiogenic shock). It aims to improve blood flow and reduce strain on the heart.
TbilisiAges 40–89 - NCT02973633RecruitingEarly Phase 1
Heart failure MRI brain-wave images after heart trouble
This early-phase study uses a special MRI scan to look at the heart in people with heart failure (and related heart changes). It aims to see whether these MRI results can better characterize heart disease and help doctors understand what’s going on.
Charlestown, MassachusettsAges 18–85 - NCT03022552Recruiting
Heart attack research add-on study on blood clotting platelets
This study looks at blood clotting (platelets) during the first phase after a heart attack. You may be able to join if you were recently diagnosed with a heart attack and received standard heart-attack blood thinners like aspirin and a second anti-platelet medicine.
New York, New YorkAges 21–99 - NCT03299569Recruiting
Learn how often Tako-tsubo heart weakness happens in Scotland
This study aims to measure how many people in Scotland develop Tako-tsubo cardiomyopathy (a temporary heart condition often triggered by stress or illness). It may help doctors better understand who is affected and plan care in the future.
Aberdeen, ScotlandAges Any age - NCT03539133Recruiting
Study heart-to-body communication after a heart attack
This study is for people who have recently had a STEMI heart attack. Researchers are looking at how the heart’s injury affects the rest of the body, which may help improve care after this type of emergency.
DüsseldorfAges 18 years+ - NCT03588286Recruiting
Check heart rhythm risk early after a heart attack
This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.
Boston, MassachusettsAges 18–85 - NCT03713866Recruiting
Imaging heart scar during ablation for certain fast heart rhythms
This trial uses special heart imaging during a catheter ablation to better map scar tissue that may be causing a dangerous fast heart rhythm (monomorphic ventricular tachycardia). It may help doctors target the problem more accurately during the procedure.
Halifax, Nova ScotiaAges 18–85 - NCT03787745Recruiting
Testing a heart-protection method after a blocked-artery procedure
This study looks at whether “ischemic postconditioning” (briefly changing blood flow right after opening a blocked heart artery) can improve outcomes in people with a specific type of heart attack. It’s meant for patients who get primary PCI (a catheter-based procedure to reopen the artery) soon after symptoms start.
CopenhagenAges 18 years+ - NCT03823547Recruiting
Research study for adults with ACS
This study is for adults who are being seen for ACS, to help improve future care. You may be invited to join if you can provide informed consent.
Apeldoorn, GelderlandAges 18 years+ - NCT03854071Recruiting
Heart and health MRI testing in healthy people or patients
This study uses MRI (a scanning test) to develop new ways to measure heart function in both healthy volunteers and people with suspected or known heart disease. It may help researchers create better heart tests that could improve future diagnosis and monitoring.
Sheffield, EnglandAges 20–80 - NCT03858777Recruiting
Blood test for heart inflammation in sarcoidosis
This study checks whether a blood “cell-free DNA” test can show when the heart is inflamed in people with cardiac sarcoidosis. It may help doctors detect active heart involvement earlier and track how disease is doing.
Iowa City, IowaAges 18 years+ - NCT03883711Recruiting
Study of treatment and outlook after heart attack
This trial studies how people do after a heart attack (or related heart injury) and may test treatments that could improve outcomes. If you’re an adult and recently had this heart event, you may be able to join after discussing consent.
Bologna, BolognaAges 18 years+ - NCT03908463Recruiting
Heart procedure registry for people who get coronary angioplasty
This trial is a registry that collects health information from adults who undergo a heart procedure called coronary angioplasty. It may help researchers understand outcomes and improve care for future patients undergoing similar treatments.
SeoulAges 19 years+ - NCT03951467Recruiting
Health literacy support to help you follow medical advice
This study tests whether a communication tool matched to your health literacy level can improve how well people follow medical recommendations after an acute episode. It may help you understand your care plan and take the right next steps at home.
BronAges 18 years+ - NCT04162171Recruiting
SBRT treatment study for steady heart rhythm VT
This study looks at using SBRT (high-precision radiation) to treat a dangerous, steady heart rhythm called monomorphic VT. It is meant for people who keep having VT even after prior ablation attempts and after trying a class III “rhythm-stabilizing” medicine.
Halifax, Nova ScotiaAges Any age - NCT04212494Recruiting
Aspirating clot during heart procedure for certain heart attacks
This trial studies whether removing (“aspirating”) a blood clot during an emergency heart procedure works better for people having a specific type of heart attack with a large clot burden. It may help improve blood flow after treatment, but it is only for patients who meet several timing and safety conditions.
Fuzhou, FujianAges 18 years+
Hear when a new Myocardial Infarct trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for myocardial infarct?
- Yes. Clin2 currently lists 318 recruiting myocardial infarct studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a myocardial infarct trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a myocardial infarct trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.